Merck Nears $10B Deal for Respiratory Drugmaker Verona: FT (1)

As part of the deal, Merck would pay $107 per American depository share for Verona, a 23% premium to the biotech’s closing price on Tuesday, Financial Times reports, citing three unidentified people familiar with the matter.

• The takeover values Verona at about $10b
• A deal could be announced as soon as Wednesday
• Merck declined to comment to FT
• Verona did not immediately respond to a request for comment: FT

To view the source of this information, click here

(Updates with more details)

To contact the reporter on this story:
Zoe Ma in Sydney at zma13@bloomberg.net

To contact the editor responsible ...